Pediatric Movement Disorders and Neuromodulation: An Overview

Area of Science:

• Neurology
• Pediatrics
• Movement Disorders

Background:

• Pediatric movement disorders are complex, heterogeneous conditions with diverse causes.
• They are broadly categorized into hypo- and hyperkinetic types, often linked to basal ganglia dysfunction.
• Abnormal movements arise from genetic factors or direct basal ganglia injuries.

Purpose of the Study:

• To review the management of pediatric movement disorders.
• To emphasize the role of neuromodulation, specifically deep brain stimulation (DBS).

Main Methods:

• Review of current literature on pediatric movement disorder management.
• Focus on pharmacotherapy, physical therapy, and invasive neuromodulation techniques.
• Analysis of deep brain stimulation outcomes in pediatric patients.

Main Results:

• Pharmacotherapy and physical therapy are primary treatments.
• Deep brain stimulation (DBS) shows promise for medication-resistant patients.
• DBS of basal ganglia and thalamic nuclei offers symptomatic benefits, reducing disability and enhancing quality of life.

Conclusions:

• Neuromodulation, particularly DBS, is an emerging and effective treatment modality.
• DBS provides significant symptomatic relief and improves quality of life for children with movement disorders.
• A multidisciplinary approach remains crucial for managing these complex conditions.